Terms: = Breast cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Treatment
21 results:
1. A rare Ewing-like small round cell tumor in prostate: a case report and literature review.
Wang Z; Ye J; Hu J; Zhang N; Yuan Y
J Cancer Res Clin Oncol; 2024 Mar; 150(3):110. PubMed ID: 38427070
[TBL] [Abstract] [Full Text] [Related]
2. Whole-Genome Sequencing Analysis of Male breast cancer Unveils Novel Structural Events and Potential Therapeutic Targets.
Al Assaad M; Michaud O; Semaan A; Sigouros M; Tranquille M; Phan A; Levine MF; Gundem G; Medina-Martínez JS; Papaemmanuil E; Manohar J; Wilkes D; Sboner A; Hoda SAF; Elemento O; Mosquera JM
Mod Pathol; 2024 Apr; 37(4):100452. PubMed ID: 38369186
[TBL] [Abstract] [Full Text] [Related]
3. TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with smarca4 and regulating its targets
Zhou C; Wang D; Li J; Wang Q; Wo L; Zhang X; Hu Z; Wang Z; Zhan M; He M; Hu G; Chen X; Shen K; Chen GQ; Zhao Q
Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2117988119. PubMed ID: 36126099
[TBL] [Abstract] [Full Text] [Related]
4. Redistribution of the SWI/SNF Complex Dictates Coordinated Transcriptional Control over Epithelial-Mesenchymal Transition of Normal breast Cells through TGF-β Signaling.
Jdeed S; Lengyel M; Uray IP
Cells; 2022 Aug; 11(17):. PubMed ID: 36078038
[TBL] [Abstract] [Full Text] [Related]
5. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
[TBL] [Abstract] [Full Text] [Related]
6. Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana.
Anwar T; Rufail ML; Djomehri SI; Gonzalez ME; Lazo de la Vega L; Tomlins SA; Newman LA; Kleer CG
Mod Pathol; 2020 Aug; 33(8):1537-1545. PubMed ID: 32152520
[TBL] [Abstract] [Full Text] [Related]
7. Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer.
Wu X; Zhang X; Yu L; Zhang C; Ye L; Ren D; Li Y; Sun X; Yu L; Ouyang Y; Chen X; Song L; Liu P; Lin X
Oncogene; 2020 Mar; 39(12):2568-2582. PubMed ID: 31988454
[TBL] [Abstract] [Full Text] [Related]
8. Persistent Use of Extended Fractionation Palliative Radiotherapy for Medicare Beneficiaries With Metastatic breast cancer, 2011 to 2014.
Yu JB; Pollack CE; Herrin J; Zhu W; Soulos PR; Xu X; Gross CP
Am J Clin Oncol; 2019 Jun; 42(6):493-499. PubMed ID: 31033511
[TBL] [Abstract] [Full Text] [Related]
9. Chromatin Regulators as a Guide for cancer treatment Choice.
Gurard-Levin ZA; Wilson LO; Pancaldi V; Postel-Vinay S; Sousa FG; Reyes C; Marangoni E; Gentien D; Valencia A; Pommier Y; Cottu P; Almouzni G
Mol Cancer Ther; 2016 Jul; 15(7):1768-77. PubMed ID: 27196757
[TBL] [Abstract] [Full Text] [Related]
10. Targeting the chromatin remodeling enzyme brg1 increases the efficacy of chemotherapy drugs in breast cancer cells.
Wu Q; Sharma S; Cui H; LeBlanc SE; Zhang H; Muthuswami R; Nickerson JA; Imbalzano AN
Oncotarget; 2016 May; 7(19):27158-75. PubMed ID: 27029062
[TBL] [Abstract] [Full Text] [Related]
11. Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.
Katoh M
Epigenomics; 2016 Feb; 8(2):285-305. PubMed ID: 26411517
[TBL] [Abstract] [Full Text] [Related]
12. Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex.
Giessrigl B; Schmidt WM; Kalipciyan M; Jeitler M; Bilban M; Gollinger M; Krieger S; Jäger W; Mader RM; Krupitza G
Br J Cancer; 2013 Nov; 109(10):2751-62. PubMed ID: 24169358
[TBL] [Abstract] [Full Text] [Related]
13. Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.
Haiman CA; Garcia RR; Hsu C; Xia L; Ha H; Sheng X; Le Marchand L; Kolonel LN; Henderson BE; Stallcup MR; Greene GL; Press MF
BMC Cancer; 2009 Jan; 9():43. PubMed ID: 19183483
[TBL] [Abstract] [Full Text] [Related]
14. Roles of coactivator proteins in dioxin induction of CYP1A1 and CYP1B1 in human breast cancer cells.
Taylor RT; Wang F; Hsu EL; Hankinson O
Toxicol Sci; 2009 Jan; 107(1):1-8. PubMed ID: 18842620
[TBL] [Abstract] [Full Text] [Related]
15. Convergence on chromatin of non-genomic and genomic pathways of hormone signaling.
Vicent GP; Ballaré C; Nacht AS; Clausell J; Subtil-Rodríguez A; Quiles I; Jordan A; Beato M
J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):344-9. PubMed ID: 18417338
[TBL] [Abstract] [Full Text] [Related]
16. Inhibition of cyclin D1 gene transcription by Brg-1.
Rao M; Casimiro MC; Lisanti MP; D'Amico M; Wang C; Shirley LA; Leader JE; Liu M; Stallcup M; Engel DA; Murphy DJ; Pestell RG
Cell Cycle; 2008 Mar; 7(5):647-55. PubMed ID: 18239461
[TBL] [Abstract] [Full Text] [Related]
17. Estrogen receptor alpha and the activating protein-1 complex cooperate during insulin-like growth factor-I-induced transcriptional activation of the pS2/TFF1 gene.
Baron S; Escande A; Albérola G; Bystricky K; Balaguer P; Richard-Foy H
J Biol Chem; 2007 Apr; 282(16):11732-41. PubMed ID: 17317669
[TBL] [Abstract] [Full Text] [Related]
18. The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs.
Fasching PA; von Minckwitz G; Fischer T; Kaufmann M; Schultz-Zehden B; Beck H; Lux MP; Jacobs V; Meden H; Kiechle M; Beckmann MW; Paepke S
Breast Cancer Res Treat; 2007 Jan; 101(1):95-104. PubMed ID: 17033928
[TBL] [Abstract] [Full Text] [Related]
19. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.
Rubino C; Shamsaldin A; Lê MG; Labbé M; Guinebretière JM; Chavaudra J; de Vathaire F
Breast Cancer Res Treat; 2005 Feb; 89(3):277-88. PubMed ID: 15754127
[TBL] [Abstract] [Full Text] [Related]
20. Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo.
Liu XF; Bagchi MK
J Biol Chem; 2004 Apr; 279(15):15050-8. PubMed ID: 14722073
[TBL] [Abstract] [Full Text] [Related]
[Next]
